Is Methamphetamine Abuse a Risk Factor in Parkinsonism?
- 31 December 2001
- journal article
- review article
- Published by Elsevier in NeuroToxicology
- Vol. 22 (6) , 725-731
- https://doi.org/10.1016/s0161-813x(01)00046-8
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Chronic systemic pesticide exposure reproduces features of Parkinson's diseaseNature Neuroscience, 2000
- α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque coresNeuroscience Letters, 1999
- Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shellSynapse, 1997
- Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamineEuropean Journal of Pharmacology, 1997
- Presynaptic monoaminergic vesicles in Parkinson's disease and normal agingAnnals of Neurology, 1996
- Regulation of DOPA Decarboxylase Activity in Brain of Living RatJournal of Neurochemistry, 1995
- Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamineBrain Research, 1992
- Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving ratsNeuroscience, 1989
- The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and ManCanadian Journal of Neurological Sciences, 1984
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973